BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 22605332)

  • 1. Evidence of the involvement of O-GlcNAc-modified human RNA polymerase II CTD in transcription in vitro and in vivo.
    Ranuncolo SM; Ghosh S; Hanover JA; Hart GW; Lewis BA
    J Biol Chem; 2012 Jul; 287(28):23549-61. PubMed ID: 22605332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
    Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
    J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II.
    Comer FI; Hart GW
    Biochemistry; 2001 Jul; 40(26):7845-52. PubMed ID: 11425311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distributive O-GlcNAcylation on the Highly Repetitive C-Terminal Domain of RNA Polymerase II.
    Lu L; Fan D; Hu CW; Worth M; Ma ZX; Jiang J
    Biochemistry; 2016 Feb; 55(7):1149-58. PubMed ID: 26807597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the O-GlcNAc modification on insulin resistance and endoplasmic reticulum stress in 3T3-L1 cells.
    Sermikli BP; Aydogdu G; Yilmaz E
    Mol Biol Rep; 2020 Aug; 47(8):5927-5942. PubMed ID: 32691273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drosophila O-GlcNAcase Deletion Globally Perturbs Chromatin O-GlcNAcylation.
    Akan I; Love DC; Harwood KR; Bond MR; Hanover JA
    J Biol Chem; 2016 May; 291(19):9906-19. PubMed ID: 26957542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of the O-GlcNAc modification in the regulation of nuclear apoptosis in T cells.
    Johnson B; Opimba M; Bernier J
    Biochim Biophys Acta; 2014 Jan; 1840(1):191-8. PubMed ID: 24035784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human RNA Polymerase II Promoter Recruitment in Vitro Is Regulated by O-Linked N-Acetylglucosaminyltransferase (OGT).
    Lewis BA; Burlingame AL; Myers SA
    J Biol Chem; 2016 Jul; 291(27):14056-14061. PubMed ID: 27129214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing O-GlcNAc levels: An overview of small-molecule inhibitors of O-GlcNAcase.
    Macauley MS; Vocadlo DJ
    Biochim Biophys Acta; 2010 Feb; 1800(2):107-21. PubMed ID: 19664691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate.
    Haltiwanger RS; Grove K; Philipsberg GA
    J Biol Chem; 1998 Feb; 273(6):3611-7. PubMed ID: 9452489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-linked beta-N-acetylglucosaminylation in mouse embryonic neural precursor cells.
    Yanagisawa M; Yu RK
    J Neurosci Res; 2009 Dec; 87(16):3535-45. PubMed ID: 19598243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulating the Regulators: Mechanisms of Substrate Selection of the O-GlcNAc Cycling Enzymes OGT and OGA.
    Stephen HM; Adams TM; Wells L
    Glycobiology; 2021 Aug; 31(7):724-733. PubMed ID: 33498085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-GlcNAc and the epigenetic regulation of gene expression.
    Lewis BA; Hanover JA
    J Biol Chem; 2014 Dec; 289(50):34440-8. PubMed ID: 25336654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear factor-erythroid-2 related transcription factor-1 (Nrf1) is regulated by O-GlcNAc transferase.
    Han JW; Valdez JL; Ho DV; Lee CS; Kim HM; Wang X; Huang L; Chan JY
    Free Radic Biol Med; 2017 Sep; 110():196-205. PubMed ID: 28625484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of
    Qian K; Wang S; Fu M; Zhou J; Singh JP; Li MD; Yang Y; Zhang K; Wu J; Nie Y; Ruan HB; Yang X
    J Biol Chem; 2018 Sep; 293(36):13989-14000. PubMed ID: 30037904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-GlcNAc modification modulates the expression of osteocalcin via OSE2 and Runx2.
    Kim SH; Kim YH; Song M; An SH; Byun HY; Heo K; Lim S; Oh YS; Ryu SH; Suh PG
    Biochem Biophys Res Commun; 2007 Oct; 362(2):325-9. PubMed ID: 17707335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-GlcNAc modifications regulate cell survival and epiboly during zebrafish development.
    Webster DM; Teo CF; Sun Y; Wloga D; Gay S; Klonowski KD; Wells L; Dougan ST
    BMC Dev Biol; 2009 Apr; 9():28. PubMed ID: 19383152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.
    Pham LV; Bryant JL; Mendez R; Chen J; Tamayo AT; Xu-Monette ZY; Young KH; Manyam GC; Yang D; Medeiros LJ; Ford RJ
    Oncotarget; 2016 Dec; 7(49):80599-80611. PubMed ID: 27716624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced transfer of a photocross-linking N-acetylglucosamine (GlcNAc) analog by an O-GlcNAc transferase mutant with converted substrate specificity.
    Rodriguez AC; Yu SH; Li B; Zegzouti H; Kohler JJ
    J Biol Chem; 2015 Sep; 290(37):22638-48. PubMed ID: 26240142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feedback Regulation of
    Lin CH; Liao CC; Chen MY; Chou TY
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.